These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1186591)

  • 1. [Elevated lead concentration in the blood during treatment with coumarin derivatives].
    Loll H
    Med Lab (Stuttg); 1975 Aug; 28(8):177-9. PubMed ID: 1186591
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenprocoumon therapy during pregnancy: case report and comparison of the teratogenic risk of different coumarin derivatives.
    Gärtner BC; Seifert CB; Michalk DV; Roth B
    Z Geburtshilfe Perinatol; 1993; 197(6):262-5. PubMed ID: 8147045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lead concentration in blood during treatment with coumarin derivatives].
    Fischer H; Wehran HI
    Z Arztl Fortbild (Jena); 1978 Mar; 72(5):211. PubMed ID: 418581
    [No Abstract]   [Full Text] [Related]  

  • 4. [Coumarin-induced necrosis].
    Dtsch Med Wochenschr; 1991 Dec; 116(49):1893. PubMed ID: 1743103
    [No Abstract]   [Full Text] [Related]  

  • 5. Maculopapular rash due to coumarin derivatives.
    Kruis-de Vries MH; Stricker BH; Coenraads PJ; Nater JP
    Dermatologica; 1989; 178(2):109-11. PubMed ID: 2522402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonists of Vitamin K-Popular Coumarin Drugs and New Synthetic and Natural Coumarin Derivatives.
    Kasperkiewicz K; Ponczek MB; Owczarek J; Guga P; Budzisz E
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32213944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extent and quality of anti-coagulation treatment with coumarin derivatives by the Dutch Thrombosis Services].
    van Geest-Daalderop JH; Sturk A; Levi M; Adriaansen HJ
    Ned Tijdschr Geneeskd; 2004 Apr; 148(15):730-5. PubMed ID: 15119208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Phenprocoumon-induced jaundice.
    den Boer W; Loeliger EA
    Lancet; 1976 Apr; 1(7965):912. PubMed ID: 58178
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The conus-cauda syndrome in occult ependymoma of the filum terminale with hemorrhagic infarction during anticoagulant therapy].
    Manz F; Fantis A
    Nervenarzt; 1976 May; 47(5):338-9. PubMed ID: 1272497
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intracranial and intraspinal hemorrhages in treatment with coumarin derivatives. Catamnesis of 63 cases between 1978 and 1986].
    Moskopp D; Brassel F; Ries F
    Klin Wochenschr; 1987 Aug; 65(16):781-90. PubMed ID: 3657042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vitamin K-controlled diet: problems and prospects].
    Miggiano GA; Robilotta L
    Clin Ter; 2005; 156(1-2):41-6. PubMed ID: 16080660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of coumarin-induced necrosis].
    Meskó K; Katona K
    Schweiz Rundsch Med Prax; 1972 Jun; 61(26):861-4. PubMed ID: 4636080
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug interactions in coumarin anticoagulation].
    Kessler P
    Vnitr Lek; 1999 Aug; 45(8):490-5. PubMed ID: 11045152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolism and coumarin overdosage in a 19-year-old female: impact of pharmacogenetics.
    Brenner C; Huber B; Becker A; Ostermann H; Becker C; Steinbeck G; Franz WM
    Clin Genet; 2010 Nov; 78(5):499-501. PubMed ID: 21039429
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanism of action of coumarin anti-coagulants (author's transl)].
    Martius F
    Ther Umsch; 1977 May; 34(5):329-33. PubMed ID: 867312
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antihemorrhagic activity of vitamin K 1. (Experimental and clinical results of its use in hemorrhages caused by coumarins].
    Iriarte Ezcurdia JA; Babio San Salvador JL
    Rev Clin Esp; 1966 Jul; 102(1):26-8. PubMed ID: 5919713
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vitamin K1, elective antidote of coumarin derivatives].
    IZARN P
    Montp Med; 1954 Nov; 46(5):321-5. PubMed ID: 14370106
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent coumarin-induced skin necrosis in a patient with an acquired functional protein C deficiency.
    Teepe RG; Broekmans AW; Vermeer BJ; Nienhuis AM; Loeliger EA
    Arch Dermatol; 1986 Dec; 122(12):1408-12. PubMed ID: 3789774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Teratogenic effect of coumarin derivatives].
    Weenink GH; van Dijk-Wierda CA; Meyboom RH; Koppe JG; Staalman CR; Treffers PE
    Ned Tijdschr Geneeskd; 1981 May; 125(18):702-6. PubMed ID: 7231584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.